We retain a BUY rating on the stock assigning a multiple of 17x FY23E EPS to arrive at a target price of Rs 1,550/share (12% upside) on the back of the CV recovery cycle, new products, and cost rat...
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.